Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Theys

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
ESMO Gastrointestinal Oncology|April 17, 2026
Revisiting cholesterol metabolism in hepatocellular carcinoma: a hidden driver of systemic therapy responseL M Stoffels, E S Espinoza Rodriguez, J Theys, et al.
Radiation Research|April 17, 2001
The use of radiation-induced bacterial promoters in anaerobic conditions: a means to control gene expression in clostridium-mediated therapy for cancerS Nuyts, L Van Mellaert, J Theys, et al.
Anticancer Research|June 9, 2001
Increasing specificity of anti-tumor therapy: cytotoxic protein delivery by non-pathogenic clostridia under regulation of radio-induced promotersS Nuyts, J Theys, W Landuyt, et al.
Anti-Cancer Drugs|March 20, 2002
Clostridium spores for tumor-specific drug deliveryS Nuyts, L Van Mellaert, J Theys, et al.
Cancer Detection and Prevention|July 23, 2002
Clostridium as a tumor-specific delivery system of therapeutic proteinsJ Theys, A W Landuyt, S Nuyts, et al.
Gene Therapy|August 18, 2001
Radio-responsive recA promoter significantly increases TNFalpha production in recombinant clostridia after 2 Gy irradiationS Nuyts, L Van Mellaert, J Theys, et al.
Cancer Gene Therapy|June 8, 2001
Specific targeting of cytosine deaminase to solid tumors by engineered Clostridium acetobutylicumJ Theys, W Landuyt, S Nuyts, et al.
Current Gene Therapy|May 24, 2003
Tumor-specific gene delivery using genetically engineered bacteriaJ Theys, S Barbé, W Landuyt, et al.
International Journal of Radiation Biology|April 11, 2000
The potential therapeutic gain of radiation-associated gene therapy with the suicide gene cytosine deaminaseP Lambin, S Nuyts, W Landuyt, et al.
European Journal of Cancer (Oxford, England : 1990)|January 23, 2002
Hypoxia as a target for combined modality treatmentsB G Wouters, S A Weppler, M Koritzinsky, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
ESMO Gastrointestinal Oncology|April 17, 2026
Revisiting cholesterol metabolism in hepatocellular carcinoma: a hidden driver of systemic therapy responseL M Stoffels, E S Espinoza Rodriguez, J Theys, et al.
Radiation Research|April 17, 2001
The use of radiation-induced bacterial promoters in anaerobic conditions: a means to control gene expression in clostridium-mediated therapy for cancerS Nuyts, L Van Mellaert, J Theys, et al.
Anticancer Research|June 9, 2001
Increasing specificity of anti-tumor therapy: cytotoxic protein delivery by non-pathogenic clostridia under regulation of radio-induced promotersS Nuyts, J Theys, W Landuyt, et al.
Anti-Cancer Drugs|March 20, 2002
Clostridium spores for tumor-specific drug deliveryS Nuyts, L Van Mellaert, J Theys, et al.
Cancer Detection and Prevention|July 23, 2002
Clostridium as a tumor-specific delivery system of therapeutic proteinsJ Theys, A W Landuyt, S Nuyts, et al.
Gene Therapy|August 18, 2001
Radio-responsive recA promoter significantly increases TNFalpha production in recombinant clostridia after 2 Gy irradiationS Nuyts, L Van Mellaert, J Theys, et al.
Cancer Gene Therapy|June 8, 2001
Specific targeting of cytosine deaminase to solid tumors by engineered Clostridium acetobutylicumJ Theys, W Landuyt, S Nuyts, et al.
Current Gene Therapy|May 24, 2003
Tumor-specific gene delivery using genetically engineered bacteriaJ Theys, S Barbé, W Landuyt, et al.
International Journal of Radiation Biology|April 11, 2000
The potential therapeutic gain of radiation-associated gene therapy with the suicide gene cytosine deaminaseP Lambin, S Nuyts, W Landuyt, et al.
European Journal of Cancer (Oxford, England : 1990)|January 23, 2002
Hypoxia as a target for combined modality treatmentsB G Wouters, S A Weppler, M Koritzinsky, et al.
Pageof 2